Bliss GVS
- Product NDC
- 72701-106
- 11-digit product format
- 727010106
- Labeler code
- 72701
- Product ID
- 72701-106_241d90c0-3c82-72e1-e063-6294a90a6272
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Glycerin
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Bliss GVS Pharma Limited
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-01-20
- Substance
- GLYCERIN
- Active strength
- 2 g/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 72701-106-50 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 72701-106-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 72701-106-05 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 72701-106-25 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 72701-106-50 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 72701-106-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 72701-106-05 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 72701-106-25 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 72701-106-50 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 72701-106-12 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 72701-106-05 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 72701-106-25 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 72701-106-50 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 72701-106-12 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 72701-106-05 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 72701-106-25 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 72701-106-50 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 72701-106-12 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 72701-106-05 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 72701-106-25 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bliss GVS
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCERIN | 2 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| PDC6A3C0OX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 104155 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1a3982a1-9ce9-4a1a-ba73-ebe2d8647109 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 72701-106-05 | 2024-10-10 | Glycerin Suppositories |
| 72701-106-12 | 2024-10-10 | Glycerin Suppositories |
| 72701-106-25 | 2024-10-10 | Glycerin Suppositories |
| 72701-106-50 | 2024-10-10 | Glycerin Suppositories |
| 72701-106-05 | 2024-01-30 | Glycerin Suppositories |
| 72701-106-12 | 2024-01-30 | Glycerin Suppositories |
| 72701-106-25 | 2024-01-30 | Glycerin Suppositories |
| 72701-106-50 | 2024-01-30 | Glycerin Suppositories |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72701-106-05 | Bliss GVS | 5 in 1 BLISTER PACK | SUPPOSITORY | 5 | 2 | |
| 72701-106-05 | Bliss GVS | 20 in 1 CARTON | SUPPOSITORY | 20 | 2 | |
| 72701-106-12 | Bliss GVS | 2 in 1 CARTON | SUPPOSITORY | 2 | 2 | |
| 72701-106-12 | Bliss GVS | 6 in 1 BLISTER PACK | SUPPOSITORY | 6 | 2 | |
| 72701-106-25 | Bliss GVS | 5 in 1 BLISTER PACK | SUPPOSITORY | 5 | 2 | |
| 72701-106-25 | Bliss GVS | 5 in 1 CARTON | SUPPOSITORY | 5 | 2 | |
| 72701-106-50 | Bliss GVS | 10 in 1 CARTON | SUPPOSITORY | 10 | 2 | |
| 72701-106-50 | Bliss GVS | 5 in 1 BLISTER PACK | SUPPOSITORY | 5 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 104155 | glycerin 2 GM Rectal Suppository | PSN | 1a3982a1-9ce9-4a1a-ba73-ebe2d8647109 | 2 |
| 104155 | glycerin 2000 MG Rectal Suppository | SCD | 1a3982a1-9ce9-4a1a-ba73-ebe2d8647109 | 2 |
| 104155 | glycerin 2 GM Rectal Suppository | SY | 1a3982a1-9ce9-4a1a-ba73-ebe2d8647109 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72701-106-05 | 72701010605 | 20 BLISTER PACK in 1 CARTON (72701-106-05) / 5 SUPPOSITORY in 1 BLISTER PACK | 20 blister pack | 2020-01-20 | 0000-00-00 | No | No | Current |
| 72701-106-12 | 72701010612 | 2 BLISTER PACK in 1 CARTON (72701-106-12) / 6 SUPPOSITORY in 1 BLISTER PACK | 2 blister pack | 2020-01-20 | 0000-00-00 | No | No | Current |
| 72701-106-25 | 72701010625 | 5 BLISTER PACK in 1 CARTON (72701-106-25) / 5 SUPPOSITORY in 1 BLISTER PACK | 5 blister pack | 2020-01-20 | 0000-00-00 | No | No | Current |
| 72701-106-50 | 72701010650 | 10 BLISTER PACK in 1 CARTON (72701-106-50) / 5 SUPPOSITORY in 1 BLISTER PACK | 10 blister pack | 2020-01-20 | 0000-00-00 | No | No | Current |